Table 2.
Correlations of CDK14 staining with TTF-1, CK5/6, and Ki67 staining in patients with non-small cell lung cancer.
| Variables, n (%) | Strong CDK14 staining (n = 129) | Weak CDK14 staining (n = 64) | P |
|---|---|---|---|
| TTF-1 | <0.001 | ||
| Strong | 113 (87.60) | 13 (20.31) | |
| Weak | 16 (12.40) | 51 (79.69) | |
| CK5/6 | <0.001 | ||
| Strong | 91 (70.54) | 22 (34.38) | |
| Weak | 38 (29.46) | 42 (65.63) | |
| Ki67 | <0.001 | ||
| Strong | 86 (66.67) | 20 (31.25) | |
| Weak | 43 (33.33) | 44 (68.75) |
CDK14, cyclin-dependent kinase 14; TTF-1, thyroid transcription factor 1; CK5/6, cytokeratin 5/6.